Loading...
Market
How will Illinois use the $45 million settlement from CVS Caremark by December 31, 2024?
2
Resolution / Starting Odds
Healthcare programs • 25%
Education programs • 25%
Infrastructure projects • 25%
Other • 25%
Official announcements from the Illinois government
Story
CVS Caremark to Pay $45 Million Settlement to Illinois Over Drug Rebates via Subsidiary Zinc
Jul 24, 2024, 10:39 AM
CVS Caremark has agreed to pay at least $45 million to the state of Illinois to settle allegations that it failed to pass drug rebates through to the state during a recent four-year period. The settlement follows an investigation by the Illinois Attorney General, which found that CVS Caremark, through its subsidiary Zinc, inappropriately pocketed drug rebates using a rebate aggregator. This settlement is expected to add to the increasing scrutiny of pharmacy benefit managers (PBMs) and their role in the pharmaceutical pricing system.
View original story
Similar markets
Health care expenses • 25%
Property damage repairs • 25%
Relocation costs • 25%
Other • 25%
Medical care improvements • 25%
Legal fees and settlements • 25%
Administrative costs • 25%
Other • 25%
Opioid addiction treatment programs • 25%
Support services for affected families • 25%
Public health initiatives • 25%
Other • 25%
Prevention programs • 25%
Treatment facilities • 25%
Public awareness campaigns • 25%
Other • 25%
Education programs • 25%
Rehabilitation centers • 25%
Community outreach • 25%
Other • 25%
Announce internal policy changes • 25%
Face additional lawsuits • 25%
No significant actions taken • 25%
Announce new partnerships or acquisitions • 25%
Public services • 25%
Debt repayment • 25%
Tax rebates • 25%
Other • 25%
Completed • 25%
Ongoing • 25%
Delayed • 25%
Cancelled • 25%
State of Hawaii • 25%
Maui County • 25%
Utilities • 25%
Insurers • 25%
Settlement reached • 25%
CVS found liable • 25%
CVS not found liable • 25%
Case dismissed • 25%
Utah • 25%
California • 25%
Arizona • 25%
Nevada • 25%
Funds distributed to claimants • 33%
Funds withheld • 33%
Funds under litigation • 33%